If recommended by a doctor, use GLP-1 agonists to help manage diabetes or attain a healthy weight For people with type 2 diabetes, GLP-1 agonists lower the risk of serious complications, including heart and kidney problems
The makers of the weight loss medication, Novo Nordisk, has also filed for a label expansion in the European Union, with a decision expected in 2024.
While side effect profiles are expected to mirror those of injectable semaglutide (such as nausea, vomiting, and constipation), the incidence and severity remain to be fully characterized through larger-scale trials
Nystrm T, Gonon AT, Sjholm A, Pernow J
Erhard was the first female physician in Minnesota to offer MonaLisa Touch and ThermiVa Vaginal Tightening treatments
Bioavailability through oral routes is generally lower than subcutaneous injection, which means effective dosing may differ